Kastelein JJ - Search Results

1

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.

Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJ; ODYSSEY LONG TERM Investigators. Robinson JG, et al. Among authors: kastelein jj. N Engl J Med. 2015 Apr 16;372(16):1489-99. doi: 10.1056/NEJMoa1501031. Epub 2015 Mar 15. N Engl J Med. 2015. PMID: 25773378 Free article. Clinical Trial.

2

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study.

de Grooth GJ, Kuivenhoven JA, Stalenhoef AF, de Graaf J, Zwinderman AH, Posma JL, van Tol A, Kastelein JJ. de Grooth GJ, et al. Among authors: kastelein jj. Circulation. 2002 May 7;105(18):2159-65. doi: 10.1161/01.cir.0000015857.31889.7b. Circulation. 2002. PMID: 11994249 Clinical Trial.

3

Declaring war on undertreatment: rationale for an aggressive approach to lowering cholesterol.

van Dam M, van Wissen S, Kastelein JJ. van Dam M, et al. Among authors: kastelein jj. J Cardiovasc Risk. 2002 Apr;9(2):89-95. doi: 10.1177/174182670200900204. J Cardiovasc Risk. 2002. PMID: 12006916 Review.

4

Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia.

de Jongh S, Lilien MR, Bakker HD, Hutten BA, Kastelein JJ, Stroes ES. de Jongh S, et al. Among authors: kastelein jj. Atherosclerosis. 2002 Jul;163(1):193-7. doi: 10.1016/s0021-9150(02)00003-5. Atherosclerosis. 2002. PMID: 12048139

5

Measurement of subclinical atherosclerosis: beyond risk factor assessment.

Bisoendial RJ, Hovingh GK, de Groot E, Kastelein JJ, Lansberg PJ, Stroes ES. Bisoendial RJ, et al. Among authors: kastelein jj. Curr Opin Lipidol. 2002 Dec;13(6):595-603. doi: 10.1097/00041433-200212000-00002. Curr Opin Lipidol. 2002. PMID: 12441883 Review.

6

Early statin therapy restores endothelial function in children with familial hypercholesterolemia.

de Jongh S, Lilien MR, op't Roodt J, Stroes ES, Bakker HD, Kastelein JJ. de Jongh S, et al. Among authors: kastelein jj. J Am Coll Cardiol. 2002 Dec 18;40(12):2117-21. doi: 10.1016/s0735-1097(02)02593-7. J Am Coll Cardiol. 2002. PMID: 12505222 Free article. Clinical Trial.

7

Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein.

Bisoendial RJ, Hovingh GK, Levels JH, Lerch PG, Andresen I, Hayden MR, Kastelein JJ, Stroes ES. Bisoendial RJ, et al. Among authors: kastelein jj. Circulation. 2003 Jun 17;107(23):2944-8. doi: 10.1161/01.CIR.0000070934.69310.1A. Epub 2003 May 27. Circulation. 2003. PMID: 12771001 Clinical Trial.

8

Subclinical atherosclerosis as a target of therapy: potential role of statins.

Kastelein JJ, Stroes ES, de Groot E. Kastelein JJ, et al. Am J Cardiol. 2004 Mar 15;93(6):737-40. doi: 10.1016/j.amjcard.2003.11.072. Am J Cardiol. 2004. PMID: 15019880 Review. No abstract available.

9

Local overexpression of C-type natriuretic peptide ameliorates vascular adaptation of porcine hemodialysis grafts.

Rotmans JI, Verhagen HJ, Velema E, de Kleijn DP, van den Heuvel M, Kastelein JJ, Pasterkamp G, Stroes ES. Rotmans JI, et al. Among authors: kastelein jj. Kidney Int. 2004 May;65(5):1897-905. doi: 10.1111/j.1523-1755.2004.00598.x. Kidney Int. 2004. PMID: 15086933 Free article.

10

New risk factors for atherosclerosis and patient risk assessment.

Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P. Fruchart JC, et al. Among authors: kastelein jj. Circulation. 2004 Jun 15;109(23 Suppl 1):III15-9. doi: 10.1161/01.CIR.0000131513.33892.5b. Circulation. 2004. PMID: 15198961 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

892 results

Search Page